N/A

Loading page data
Please wait a moment
Second Floor, 150 Fleet Street,
London, EC4A 2DQ.
+44 203-837-5656
108 W 39th Street, Ste 1006,
PMB2219, New York, NY 10018
+1 646-878-6329
IT Unit No. 504, 5th Floor, Icon
Tower, Baner, Pune - 411045.
+91 906 779 3500





Spine disorders hit a good number of population, either through degrading health conditions or traumatic events. Spinal stabilization devices are designed to provide support and stabilization to patients with a severe spinal condition. Degenerative disc disease, herniated disc, spinal stenosis are few examples of spinal disorders having a high incidence rate on a global level.
Spinal stabilization devices are generally used for patients with the chronic spinal condition and specific conservative procedures are done for mild-to-moderate spinal conditions.
Still, the target population is rising, with age, lifestyle condition and many other parallel conditions which leads to lads to a spinal disorder. A large portion of spinal surgeries involve spinal fusion and this practice is seen across regions where doctors tend to follow this routine.
Spinal stabilization devices on other hand have received no FDA approval, although FDA has specified off label marketing for spinal stabilization devices. FDA has provided clearance for the use of spine stabilization devices in different sections of spinal fusion.
The global spinal stabilization devices market is expected to see quality growth in the near future, due to an increase in use and entry of new product launches. The cost of such spinal implant treatment is high, and with a change in demographics and economic conditions, the present treatment with spinal stabilization devices is not an affordable treatment option for greater number of a prevalent population with spinal disorders.
There are other alternatives for spinal stabilization devices for spinal disorders like artificial discs, annulus repair, spinal fusion instrumentation, and vertebral compression fracture treatment products.
The type of disorder directs the type of device used for treatment, therefore, leaving spinal stabilization devices as mere optional products in entire spinal implants. Such factors limit the market for spinal stabilization devices and potential of spine concerned cases remain undiagnosed in many poor socio-economic countries.
There are things that require attention for the growth of this spinal stabilization devices market, as cost reductions for such device and positive reimbursements scenarios would lead to a better network for this market.